Abstract:Objective: To study the inhibitory effect of antimicrobial peptide LL-37 on Candida albicans through its ability to promote the secretion of immune factors by vaginal epithelial cells. Methods: (1) LL-37 prokaryotic expression vector pET-Duet/LL-37 was constructed and its expression was induced in Escherichia coli M15. The expressed LL-37 fusion protein was purified and identified by western blot. Antifungal activity of the purified protein was initially identified by Kirby-Bauer (K-B) method. (2) Purified LL-37 protein was added to human vaginal epithelial cells co-cultured with Candida, and inhibitory effect on Candida growth was determined by the glucose consumption method. Interferon γ (IFN-γ), interleukin 10 (IL-10) concentration and IFN-γ/IL-10 ratio were measured by ELISA at different time points. Results: (1) LL-37 fusion protein was purified to 96% purity at a concentration of 433.92 μg/ml, and was shown to possess anti-fungal activity confirmed by the K-B method. (2) A Candida-vaginal epithelial cells co-culture system was successfully constructed. LL-37 recombinant protein inhibited the growth of Candida with absorbance values significantly higher in the treatment group compared to the control group at all measured time points (12-hour: 3.008±0.003 versus 2.967±0.003, 24-hour: 2.941±0.003 versus 2.601±0.003, 48-hour: 2.893 ± 0.004 versus 2.409 ± 0.003; all P<0.01). Furthermore, the rate of decrease was also much slower compared to the control group. In both control and experimental groups, IFN-γ and IL-10 secretion levels were observed to rise at first peaking at 24 hours and subsequently decrease. For each time period, IFN-γ concentration in the experimental group was significantly higher at 24 hours compared to the control group [(104.00 ± 1.07) versus (85.17 ± 0.28) pg/ml,P<0.01]. In contrast, IL-10 concentrations were significantly lower than the control group at all time points (P<0.01). IFN-γ/IL-10 ratio was also observed to be significantly higher than the control group at all measured time points (P<0.01). Conclusions: (1) Recombinant protein LL-37 could significantly inhibit the growth of Candida. (2) By influencing the secretion of immune factors such as IFN-γ, IL-10, etc, recombinant protein LL-37 is able to adjust vaginal epithelial cells local immunity, and enhance resistance to Candida infection.

Recombinant human interleukin 17A enhances the anti-Candida effect of human oral mucosal epithelial cells by inhibiting Candida albicans growth and inducing antimicrobial peptides secretion

Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages.

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis

Extracellular interleukin-17F has a protective effect in oral tongue squamous cell carcinoma

Antimicrobial Effect of Extracellular Vesicles Derived From Human Oral Mucosal Epithelial Cells on <i>Candida albicans</i>

Effects of Candida Albicans Infection on Defense Effector Secretion by Human Oral Mucosal Epithelial Cells.

Recombinant Human IFNα-2b Response Promotes Vaginal Epithelial Cells Defense Against Candida Albicans

IL-17: A Critical Cytokine for Defense against Oral Candidiasis

A subset of IL-17 + mesenchymal stem cells possesses anti- Candida albicans effect

Different Host Immunological Response to C. Albicans by Human Oral and Vaginal Epithelial Cells

A Subset of IL-17+ Mesenchymal Stem Cells Possesses Anti-Candida Albicans Effect

[Prokaryotic expression and purification of antimicrobial peptide LL-37 and the inhibiting effect against Candida albicans]

Critical Role Of The Interleukin-17/Interleukin-17 Receptor Axis In Regulating Host Susceptibility To Respiratory Infection With Chlamydia Species

Combinatorial actions of IL-22 and IL-17 drive optimal immunity to oral candidiasis through SPRRs

IL-17C Amplifies Epithelial Inflammation in Human Psoriasis and Atopic Eczema

IL-17 receptor A functions to help maintain barrier integrity and limit activation of immunopathogenic response to H. pylori infection

Immunity to pathogenic mucosal C. albicans infections mediated by oral megakaryocytes activated by IL-17 and candidalysin

Cranberry proanthocyanidins inhibit the adherence properties of Candida albicans and cytokine secretion by oral epithelial cells

Risk of Candidiasis Associated with Interleukin-17 Inhibitors: Implications and Management

Type 17 immune response promotes oral epithelial cell proliferation in periodontitis

Effects of Recombinant IL‐17F Intranasal Inoculation Against Streptococcus Pneumoniae Infection in a Murine Model